{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?identifier=205406&max-ddpModified.=2019-05-22T14%3A42%3A07.519Z", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?identifier=205406&max-ddpModified.=2019-05-22T14%3A42%3A07.519Z", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?identifier=205406&max-ddpModified.=2019-05-22T14%3A42%3A07.519Z&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?identifier=205406&_page=0&max-ddpModified.=2019-05-22T14%3A42%3A07.519Z", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?identifier=205406&max-ddpModified.=2019-05-22T14%3A42%3A07.519Z", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?identifier=205406&max-ddpModified.=2019-05-22T14%3A42%3A07.519Z", "items" : [{"_about" : "http://data.parliament.uk/resources/1035142", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1035142/answer", "answerText" : {"_value" : "

Supplies of naproxen tablets are currently available but are limited due to a manufacturing issue that has affected the availability of the active pharmaceutical ingredient. The Department is working closely with all suppliers to resolve the situation and expedite further deliveries as soon as possible. Additional deliveries of naproxen are expected throughout January and February.<\/p>

<\/p>

As a responsible Government, we continue to prepare proportionately for all scenarios following our exit from the European Union in March 2019, including a \u2018no-deal\u2019 scenario. This includes asking pharmaceutical companies to have six weeks additional supply of all pharmacy and prescription-only medicines which enter the United Kingdom from, or via, the European Union or European Economic Area over and above their business as usual stocks.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1585", "label" : {"_value" : "Biography information for Stephen Hammond"} } , "answeringMemberConstituency" : {"_value" : "Wimbledon"} , "answeringMemberPrinted" : {"_value" : "Stephen Hammond"} , "dateOfAnswer" : {"_value" : "2019-01-09", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "205407"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-01-09T16:31:57.82Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-01-04", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Naproxen"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the adequacy of supplies of naproxen.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4658", "label" : {"_value" : "Biography information for Alex Sobel"} } , "tablingMemberConstituency" : {"_value" : "Leeds North West"} , "tablingMemberPrinted" : [{"_value" : "Alex Sobel"} ], "uin" : "205406"} , {"_about" : "http://data.parliament.uk/resources/77365", "AnsweringBody" : [{"_value" : "Ministry of Defence"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/77365/answer", "answerText" : {"_value" : "

The UK Government has no plans to move the strategic nuclear deterrent from Her Majesty\u2019s Naval Base Clyde, and has not considered options for moving the deterrent. Any alternative solution would come at huge cost to the taxpayer.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/77", "label" : {"_value" : "Biography information for Sir Julian Brazier"} } , "answeringMemberConstituency" : {"_value" : "Canterbury"} , "answeringMemberPrinted" : {"_value" : "Mr Julian Brazier"} , "dateOfAnswer" : {"_value" : "2014-07-21", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/77365/answer/previousversion/11733", "answeringMember" : {"_about" : "http://data.parliament.uk/members/77", "label" : {"_value" : "Biography information for Sir Julian Brazier"} } , "answeringMemberConstituency" : {"_value" : "Canterbury"} , "answeringMemberPrinted" : {"_value" : "Mr Julian Brazier"} } , "questionFirstAnswered" : [{"_value" : "2014-07-21T16:54:14.3281536Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "11"} , "answeringDeptShortName" : {"_value" : "Defence"} , "answeringDeptSortName" : {"_value" : "Defence"} , "date" : {"_value" : "2014-07-11", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Trident"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Defence, what assessment he has made of the cost to the public purse of the removal of Trident from Scotland.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/576", "label" : {"_value" : "Biography information for Sandra Osborne"} } , "tablingMemberConstituency" : {"_value" : "Ayr, Carrick and Cumnock"} , "tablingMemberPrinted" : [{"_value" : "Sandra Osborne"} ], "uin" : "205406"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 2, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }